Samsung Venture Invests in Genome Insight $23M Series B-2 Financing

November 1, 2023Client News

Gunderson Dettmer represented client Samsung Venture Investment Corporation in its participation of the $23 million Series B-2 financing of Genome Insight, a precision healthcare solutions company. Genome aims to deliver unparalleled bioinformatics that merges whole-genome and patient data to deliver first-in-class research and discovery, precision diagnostics and treatments. The new capital will support Genome Insight’s pursuit of bringing whole-genome based precision diagnostics to routine clinical care.

In the announcement of the transaction, Genome Insight founder and CEO Young Seok Ju said, "Genomic data has the potential to unlock a new era in healthcare. We envision a future where genomic information is integral to standard patient care."

The Gunderson Dettmer deal team was led by Bennett Yee and included Oh Sung Kwon and Alan Gao.

Samsung Venture Investment Corporation
Genome Insight